Search results for "Biochemistry"

showing 10 items of 20172 documents

Gene Rearrangements and Other Molecular Features in Aggressive B-Cell Lymphomas of Patients with and without HIV-Infection

2015

Abstract Aggressive B-cell Lymphomas are the second most frequent AIDS-defining cancers. Few studies have compared the molecular characteristics of aggressive B-cell lymphomas in patients with and without HIV-infection; and to our knowledge, there are no reports comparing the incidence of gene rearrangements between the two groups and their impact on outcome in series treated with RCHOP. We retrospectively studied two series of patients with (N=32) and without HIV-infection (N=43) with diffuse large B-cell lymphomas (DLBCL) NOS (75% and 70%, respectively), T-rich DLCBL (13% and 5%), transformed DLBCL (3% and 14%) and double-hit (DH) DLCBL (9% and 11%) [defined by translocations affecting MY…

medicine.medical_specialtyPathologybusiness.industryIncidence (epidemiology)ImmunologyFollicular lymphomaCell BiologyHematologyCHOPmedicine.diseaseBiochemistryGastroenterologyLymphomaExact testInternational Prognostic IndexInternal medicinemedicineProgression-free survivalbusinessDiffuse large B-cell lymphomaBlood
researchProduct

6-18F-Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extra…

2010

Context: Pheochromocytomas (PHEOs) and paragangliomas (PGLs) may be better detected by 18F-fluorodihydroxyphenylalanine-positron emission tomography (FDOPA-PET) than 123I-metaiodobenzyl-guanidine (123-I-MIBG) scintigraphy. Objective: The objective of the study was to correlate functional imaging results with immunohistochemical, molecular-genetic, and biochemical findings. Design and Setting: Thirty consecutive patients with suspected PHEO/PGL presenting at a tertiary referral centre were investigated in a prospective study. Patients: Twenty-five patients had confirmed PHEO/PGL. Thirteen of 25 patients had a hereditary PHEO/PGL syndrome (two multiple endocrine neoplasia II, six succinate de…

medicine.medical_specialtyPathologymedicine.diagnostic_testbusiness.industryEndocrinology Diabetes and MetabolismBiochemistry (medical)Clinical BiochemistryMagnetic resonance imagingContext (language use)medicine.diseaseScintigraphyBiochemistryDihydroxyphenylalaninePheochromocytomachemistry.chemical_compoundEndocrinologyEndocrinologychemistryPositron emission tomographyParagangliomaInternal medicinemedicineMultiple endocrine neoplasiabusinessThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Systematic review of the association between particulate matter exposure and autism spectrum disorders

2017

Particulate matter (PM) as an environmental pollutant is suspected to be associated with autism spectrum disorders. The aim of the present study was to review the epidemiological literature currently available on the relation between PM exposure and diagnosis of ASD. The PubMed database was searched from November 2015 up to January 2016 by one of the authors. We included observational studies (cohort and case control studies) published in English carried out in children within the last 10 years, measuring PM exposure and health outcomes related to ASD. 13 studies met the inclusion criteria. Four of the studies found no association between PM exposure and ASD. The other 8 studies show positi…

medicine.medical_specialtyPediatricsAutism Spectrum Disorder010501 environmental sciences01 natural sciencesBiochemistry03 medical and health sciences0302 clinical medicinePregnancyStatistical significanceEnvironmental healthEpidemiologymedicineHumansVehicle Emissions0105 earth and related environmental sciencesGeneral Environmental Sciencebusiness.industryPublic healthConfoundingmedicine.diseasePrenatal Exposure Delayed EffectsCohortAutismFemaleParticulate MatterObservational studybusiness030217 neurology & neurosurgeryCohort study
researchProduct

Luspatercept Response in ESA-NaïVe/RS+ Patients and RS- Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS)

2016

Abstract Background: Management of anemia is a common therapeutic challenge in patients with myelodysplastic syndromes (MDS). Luspatercept (ACE-536), a fusion protein containing modified activin receptor type IIB, is being developed for treatment of anemia in lower-risk MDS. Luspatercept binds GDF11 and other TGF-β superfamily ligands to promote late-stage erythroid differentiation and increase hemoglobin (Hgb) levels (Suragani R, Nat Med, 2014 and Attie K, Am J Hematol, 2014). Aims: This is an ongoing, phase 2, multicenter, open-label study to evaluate the effects of luspatercept in patient (pts) with low-intermediate risk MDS. Endpoints included erythroid response (IWG HI-E), RBC transfus…

medicine.medical_specialtyPediatricsbusiness.industryAnemiaMyelodysplastic syndromesImmunologyPhases of clinical researchCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyhemic and lymphatic diseasesPharmacodynamicsInternal medicineLuspaterceptCohortmedicineIntermediate riskbusinessLenalidomidemedicine.drugBlood
researchProduct

Muscarinic mobilization of choline in rat brain in vivo as shown by the cerebral arterio-venous difference of choline.

1987

In anesthetized rats, the choline levels of cerebrospinal fluid and plasma obtained from blood collected from peripheral vessels (carotid artery, cardiac vessels) and from the transverse sinus were determined with a radioenzymatic assay. Cortical release of choline was studied using the "cup technique." The plasma choline level of the peripheral blood (11.5 mumol/L) was lower than that of the sinus blood. The resulting cerebral arterio-venous difference of choline was negative (3.2 mumol/L) and reflected the net release of choline from the whole brain. The plasma choline levels were not different irrespective of whether the rats were anesthetized with ether, urethane, or pentobarbital. Howe…

medicine.medical_specialtyPentobarbitalAgingBiochemistryCholineVeinsCellular and Molecular Neurosciencechemistry.chemical_compoundCerebrospinal fluidIn vivoInternal medicineMuscarineBlood plasmaMuscarinic acetylcholine receptormedicineOxotremorineCholineAnimalsOsmolar ConcentrationBrainVenous PlasmaArteriesDietRatsEndocrinologychemistryCerebrovascular Circulationmedicine.drugJournal of neurochemistry
researchProduct

Effect of Prognostic Risk Classification on Temsirolimus Efficacy and Safety Outcomes in Patients with Relapsed/Refractory Mantle Cell Lymphoma

2011

Abstract Abstract 2708 Background: The simplified Mantle Cell Lymphoma International Prognostic Index (MIPI) has been shown to be a good predictor of patient survival (Blood 2008;111:558–65; Blood 2010;115:1530–1533). This post hoc study analyzed data from a randomized, phase III clinical trial investigating temsirolimus (TEM) in relapsed/refractory mantle cell lymphoma (MCL) in which TEM 175/75 (175 mg for first 3 weeks then 75 mg weekly) demonstrated significantly longer progression-free survival (PFS) vs investigator's choice of therapy (INV; 4.8 vs 1.9 months, respectively; hazard ratio [HR]=0.44; P=.0009; J Clin Oncol 2009;27:3822–9). Patients receiving TEM 175/25 (175 mg for first 3 w…

medicine.medical_specialtyPerformance statusAnemiabusiness.industryIncidence (epidemiology)ImmunologyHazard ratioCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyTemsirolimusInternational Prognostic IndexRenal cell carcinomaInternal medicinemedicineMantle cell lymphomabusinessmedicine.drugBlood
researchProduct

SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE

2014

High-density lipoproteins (HDL) are classified as atheroprotective because they are involved in transport of cholesterol to the liver, known as "reverse cholesterol transport (RCT)" exerting antioxidant and anti-inflammatory activities. There is also evidence for cytoprotective, vasodilatory, antithrombotic, and anti-infectious activities for these lipoproteins. HDLs are known by structural, metabolic and biologic heterogeneity. Thus, different methods are able to distinguish several subclasses of HDL. Different separation techniques appear to support different HDL fractions as being atheroprotective or related with lower cardiovascular (CV) risk. However, HDL particles are not always prote…

medicine.medical_specialtyPharmacologyBiologySystemic inflammationBiochemistrychemistry.chemical_compoundRisk FactorsInternal medicineDrug DiscoveryAntithromboticmedicineAnimalsHumansHdl functionalityPharmacologyCholesterolOrganic ChemistryReverse cholesterol transportBiomarker (cell)EndocrinologychemistryCardiovascular DiseasesMolecular MedicineSeparation methodlipids (amino acids peptides and proteins)Hdl subfractionscardiovascular risk electrophoresis high-density lipoprotein nuclear magnetic resonance proteome subclasses subfractions ultracentrifugation.medicine.symptomLipoproteins HDL
researchProduct

Metabolic changes in skeletal muscle of frog during exercise and recovery.

1991

medicine.medical_specialtyPhosphocreatineChemistryMusclesPhysical ExertionRana temporariaFructosephosphatesSkeletal muscleCreatineBiochemistryEndocrinologymedicine.anatomical_structureAdenosine TriphosphateInosine MonophosphateInternal medicinemedicineLactatesAnimalsEnergy MetabolismSwimmingBiochemical Society transactions
researchProduct

Effects of severe arterial hypocapnia on regional blood flow regulation, tissuePO2 and metabolism in the brain cortex of cats

1981

The effect of a stepwise decrease in PaCO2 from 3.9-1.6 kPa on rCBF, rCMRO2, tissue PO2 and concentrations of glucose, lactate, pyruvate, ATP, ADP, AMP and phosphocreatine in the brain cortex was studied in cats lightly anaesthetized with sodium pentobarbital. 1. Moderate lowering of PaCO2 to 2.5 kPa induced in all animals a homogeneous decrease of rCBF in corresponding areas of the right and left hemisphere. Mean rCBF fell from 129.2 to 103.1 ml X 100 g-1 X min-1, while rCMRO2 remained unchanged (12.7-12.9 ml X 100 g-1 X min-1). The tissue PO2 frequency histograms showed a shift to lower values without indicating the presence of brain tissue hypoxia. 2. Severe arterial hypocapnia (PaCO2 = …

medicine.medical_specialtyPhosphocreatinePhysiologyClinical BiochemistryPhosphocreatinechemistry.chemical_compoundOxygen ConsumptionHypocapniaAdenine nucleotidePhysiology (medical)Internal medicinePyruvic AcidHyperventilationmedicineAnimalsHyperventilationLactic AcidPyruvatesCerebral CortexAdenine NucleotidesCarbon DioxideHypoxia (medical)medicine.diseaseOxygenGlucoseEndocrinologymedicine.anatomical_structurechemistryCerebral cortexCerebrovascular CirculationAnesthesiaCatsLactatesVascular resistanceVascular ResistancePyruvic acidmedicine.symptomcirculatory and respiratory physiologyPflügers Archiv - European Journal of Physiology
researchProduct

Fructose 2,6-bisphosphate and glycolytic flux in skeletal muscle of swimming frog

1990

AbstractGlycolytic flux in skeletal muscle is controlled by 6-phosphofructokinase but how this is achieved is controversial. Brief exercise (swimming) in frogs caused a dramatic increase in the phosphofructokinase activator, fructose 2,6-bisphosphate, in working muscle. The kinetics of phosphofructokinase suggest that in resting muscle, the enzyme is inhibited by ATP plus citrate and that the increase in fructose 2,6-bisphosphate is part of the mechanism to activate phosphofructokinase when exercise begins. When exercise was sustained, fructose 2,6-bisphosphate in muscle was decreased as was the rate of lactate accumulation. Glycolytic flux and the content of fructose 2,6-bisphosphate appea…

medicine.medical_specialtyPhosphofructokinase-1Rana temporariaBiophysicsSkeletal musclePhysical exerciseMotor ActivityBiologyBiochemistrychemistry.chemical_compoundStructural BiologyInternal medicineFructosediphosphatesGeneticsmedicineAnimalsGlycolysisLactic AcidExerciseMolecular BiologySwimmingchemistry.chemical_classificationMusclesSkeletal muscleFructoseCell BiologyEnzyme ActivationKineticsFructose 26-bisphosphateEndocrinologymedicine.anatomical_structureEnzymeBiochemistrychemistryFructose 26-bisphosphateLactates6-PhosphofructokinaseAnuraHexosediphosphatesGlycolysisFlux (metabolism)PhosphofructokinaseFEBS Letters
researchProduct